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Background: Aerobic exercise appears to have clinical benefits for many asthmatics, yet a complete understanding
of the mechanisms underlying these benefits has not been elucidated at this time.
Purpose: The objective of this study was to determine feasibility for a larger, future study that will define the effect
of aerobic exercise on cellular, molecular, and functional measures in adults with mild-moderate asthma.
Design: Recruited subjects were randomized into usual care (sedentary) or usual care with moderate intensity
aerobic exercise treatment groups.
Setting / Participants: Nineteen adults with mild-moderate asthma but without a recent history of exercise were
recruited at the UAB Lung Health Center, Birmingham, AL.
Intervention: The exercise group underwent a 12 week walking program exercising at 60 – 75% of maximum
heart rate (HRmax). Subjects self-monitored HRmax levels using heart rate monitors; exercise diaries and recreation
center sign-in logs were also used.
Main outcome measures: Functional measures, including lung function and asthma control scores, were evaluated for
all subjects at pre- and post-study time-points; fitness measures were also assessed for subjects in the exercise group.
Peripheral blood and nasal lavage fluid were collected from all subjects at pre- and post-study visits in order to evaluate
cellular and molecular measures, including cell differentials and eosinophilic cationic protein (ECP).
Results: Sixteen subjects completed the prescribed protocol. Results show that subjects randomized to the exercise
group adhered well (80%) to the exercise prescription and exhibited a trend toward improved fitness levels upon study
completion. Both groups exhibited improvements in ACQ scores. No changes were observed in lung function (FEV1,
FEV1/FVC), cell differentials, or ECP between groups.
Conclusions: Results indicate that a moderate intensity aerobic exercise training program may improve asthma control
and fitness levels without causing asthma deterioration in adult asthmatics. As such, these findings demonstrate the
feasibility of the study protocol in preparation for a larger, clinical trial that will elucidate the functional consequences of
aerobic exercise on asthmatic cellular and molecular responses.Background
Asthma is characterized by the symptoms of wheezing,
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reproduction in any medium, provided the orAlthough multifactorial in origin, asthma is considered
an inflammatory process that is the result of an inappro-
priate immune response to common stimuli. Previous
studies have demonstrated that increased levels of in-
flammatory mediators, such as serum eosinophilic cat-
ionic protein (ECP), correlate positively with asthma
exacerbations and worsening [1,2].
Increasing evidence indicates that decreased physical
activity may play a role in the severity and increasing
prevalence of asthma [3]. We and others have reported
that, in murine asthma models, repeated bouts ofd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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airway inflammation and hyperreactivity significantly
[4–7]. Furthermore, several clinical studies suggest that
aerobic exercise training, as a part of a pulmonary re-
habilitation program, improves asthma control and over-
all physical fitness of asthmatics and reduces their
disease-related hospital admissions [3,8–10]. In accord-
ance with these studies, the American College of Sports
Medicine (ACSM) and the American Thoracic Society
(ATS) recommend the implementation of low to moder-
ate intensity aerobic exercise for asthmatic patients
[11,12]. Specifically, the ACSM suggests walking or other
forms of exercise that utilize large muscle groups
3–5 days per week at 50% of maximal exertion. The
ATS recommends exercising at 60 to 75% of maximal
work rate for 20 to 30 minutes per day 2 to 5 days per
week, and our study follows the ATS guidelines for
exercise.
Despite these reports and recommendations, however,
the physiologic basis for the clinical improvement that
many asthmatics experience with a regular exercise pro-
gram is not understood fully. The objective of this pilot
study was to determine feasibility for a larger, future
study that will define the effect of moderate intensity
aerobic exercise on cellular, molecular, and functional
measures in adults with mild-moderate severity asthma.
Nineteen subjects were randomized into two treatment
groups: usual care (sedentary) or usual care with moder-
ate intensity aerobic exercise. Subjects in the exercise
group underwent a 12 week walking program exercising
at 60 – 75% of maximum heart rate (HRmax). Outcome
indicators included functional (lung function, ACQ, fit-
ness), cellular (circulating cell differentials), and molecu-
lar (pro-inflammatory mediators, including ECP)
measures. Results show that subjects randomized to the
exercise group adhered well (80%) to the exercise pre-
scription and exhibited a trend toward improved fitness
levels as compared with sedentary controls. Both groups
exhibited improvements in Asthma Control Question-
naire (ACQ) scores. No changes were observed in lung
function (FEV1, FEV1/FVC), cell differentials, or pro-
inflammatory mediator levels, including ECP, between
groups. Despite these observations, we maintain that this
current study demonstrates the feasibility of the protocol
in preparation for a larger clinical trial that will elucidate
the functional consequences of aerobic exercise on cellu-
lar and molecular responses in asthmatic patients.
Methods
Subjects
This randomized, parallel group proof of concept study
was approved and monitored by the UAB Institutional
Review Board. Subjects were recruited from the Univer-
sity of Alabama at Birmingham (UAB) Lung HealthCenter’s Asthma Clinical Research Database from March
2009 through June 2011. Adults with mild-moderate
persistent asthma (as defined by the NAEPP guidelines
[13]) with at least a 12% FEV1 reversibility were eligible
for enrollment. A physician diagnosis of asthma and
documentation of reversible airflow obstruction was uti-
lized to exclude patients with other causes of dyspnea.
Individuals who underwent aerobic exercise regularly (3
or more times per week for more than 20 minutes at a
time) during any of the six months prior to the study
were not eligible for enrollment in order to facilitate the
examination of exercise-mediated effects on asthmatic
responses. In addition, individuals who smoked within
6 months from the start of the exercise protocol or with
greater than a 10 pack year smoking history were
excluded in order to exclude patients with chronic ob-
structive pulmonary disease (COPD). Individuals with
other major illnesses, including coronary artery disease,
congestive heart failure, stroke, severe hypertension, im-
munodeficiency states, or other conditions that would
have interfered with participation in the study or with
the proposed measurements were not eligible. In order
to facilitate high adherence and data collection rates,
individuals who were unable or unwilling to provide
consent, perform the exercise protocol, provide pre- and
post-study measurements, be contacted via telephone, or
who intended to move out of the area within 6 months
from the start of the study were excluded. Figure 1 illus-
trates the number of subjects screened and enrolled in
the study.Interventions
Subjects were recruited by the study coordinator and
randomly assigned to either usual care or usual care
with moderate intensity aerobic exercise treatment
groups (Figure 1). Permuted variable size block
randomization developed by the biostatistician was used
to allocate subjects to the two study arms. The variable
block size prevented exact knowledge of the next
randomization assignment while maintaining equal allo-
cation of subjects to the study arms throughout the
study. All subjects were provided with two zippered pil-
low encasements and one mattress protector (Royal
Heritage). These items were membrane free materials
with a pore size less than 5% to reduce subject exposure
to dust mite and dander in their bedding. In addition,
study subjects randomized to the moderate intensity aer-
obic exercise group received a 3 month free membership
to a local exercise facility at the time of the initial visit.
This allowed the study subject a secure and safe envir-
onment in which to perform the exercise protocol. This
strategy was designed to reduce adverse events asso-
ciated with allergen exposure as well as prevent drop
Screen interviewSubjects
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Figure 1 CONSORT figure of subject screening and recruitment. Fifty subjects were interviewed; thirty-one were excluded or refused. The
remaining subjects were randomized into education and education with exercise treatment groups. A total of three subjects (1 – education; 2 –
education/exercise) were withdrawn from the study because of protocol violations.
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to perform the exercise protocol.
Usual care asthma education
All subjects received a brief (approximately 30 minute)
coordinator-led educational intervention at the UAB
Lung Health Center. Educational content focused on: i)
the role of inflammation in asthma, ii) allergens that can
trigger airway inflammation, iii) tips for avoiding or re-
ducing exposure to triggers categorized as allergens
(dust, bedding, furniture, pollens, food allergies, animal
dander, mold, cockroaches), iv) caring for pillow and
mattress covers, and v) good health practice (getting
eight hours of sleep a day, drinking plenty of fluids,
relaxing, eating a balanced diet and reducing stress).
Moderate intensity aerobic exercise
Those randomized to the moderate intensity aerobic ex-
ercise group completed a 12-week exercise training pro-
gram at a frequency of 3 times per week, 30 minutes
each session, at a steady-state intensity that achieved
60 – 75% of maximum heart rate (HRmax). In order to
determine each subject’s HRmax and fitness level, sub-
jects performed a mandated graded treadmill test to vol-
itional fatigue using a modified version of the Bruce
protocol [14]; this test was performed at the UAB Clin-
ical Exercise Facility. Subjects’ fitness levels were mea-
sured in the same manner at the conclusion of the 12-
week intervention. Because subjects were using medica-
tions which may have influenced heart rate (such as
bronchodilators), we utilized the graded treadmill test toallow us to measure subjects’ true maximum heart rates
while taking their usual medications; Ratings of Per-
ceived Exertion were recorded throughout the treadmill
test. Maximal oxygen uptake in one minute (VO2max), as
measured with a metabolic cart, was accepted as accur-
ate if at least 2 of 3 physiologic criteria were met: level-
ing off of VO2 with increasing workload, respiratory
exchange ratio (RER) > 1.15, and heart rate equal to age-
predicted maximum. The target heart rate range was
then calculated for each subject.
Recommended exercise prescription included a 5 mi-
nute warm-up, 30 minutes of steady state exercise via
walking, and a 5 min cool-down; thus total exercise time
was 40 minutes per exercise bout. Compliance with this
prescription was verified via heart rate monitor readings
as described below. The exercise program was per-
formed at the UAB Recreational Center and was com-
pleted in conjunction with standard patient education
described above.
Subject visits
Subjects made three clinic visits to the UAB Lung
Health Center. At the initial visit and prior to the start
of the exercise protocol, all subjects underwent a
complete physical with a board certified pulmonologist
to ensure that the subjects were able to tolerate the exer-
cise regimen. In addition, subjects completed health his-
tory and physical activity history questionnaires and
documented asthma exacerbations at the initial visit.
ECGs (12-lead) were used to permit safety monitoring of
any previously un-diagnosed heart ailments and as part
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exercise group. Lung function measurements and sample
collection procedures (described below) were conducted
at pre- and post-study intervals.
Exercise monitoring
Subjects randomized to the exercise treatment group
were monitored for adherence to the exercise prescrip-
tion. Throughout the study, aerobic exercise subjects
were asked to wear a Polar Heart Rate Monitor (model
625X), which stores relevant exercise history informa-
tion, including heart rate target zones, exercise duration
in target zones, average heart rate, maximum heart rate,
and total exercise time. Staff instructed subjects in the
use of the heart rate monitor at the initial visit. Stored
information, including length of the exercise session and
average target heart rate during the exercise session, was
downloaded onto a computer at the post-study visits. In
addition, subjects kept a weekly exercise diary, which
included the frequency of exercise, asthma-related symp-
toms and exacerbations, the use of pillow and mattress
covers, and good health practices. Subjects submitted
the exercise logs to the study coordinator at the post-
study visits. Sign-in logs from the participating fitness
center were monitored weekly in order to verify physical
activity logs of subjects randomized to the exercise
group. Subjects were called each week to ensure they
were recording the exercise activity and to encourage
adherence. In addition, phone calls permitted investiga-
tor evaluation of any increases in asthma symptoms,
other health problems that interfered with their exercise
prescription, or problems with heart rate monitors. It
also provided direct feedback about non-compliance.
It is possible that subjects in the exercise group may
have exhibited improved asthmatic responses as a conse-
quence of increased interaction with or attention from
individuals at the fitness center. In order to control for
this interaction / attention within the exercise group,
individuals in the usual care group also received weekly
phone calls from the study coordinator. During these
brief phone calls, the study coordinator asked the sub-
ject how he/she was doing and if there was anything
related to his/her respective program with which he/she
needed assistance.
Outcome indicators
The primary outcome indicator for this study was serum
ECP. ECP is a marker of eosinophil activation found in
both lavage fluids and serum of asthmatics. It has been
demonstrated to correlate with asthma exacerbations
and worsening as well as the effectiveness of asthma-
related therapies [1,2]. Secondary outcome indicators
included asthma control scores, airway and peripheral
blood inflammatory markers (nasal lavage ECP, serumcytokines, peripheral blood immune cell populations),
lung function parameters (FEV1, FEV1/FVC), and fitness
measures (VO2 peak, HR peak, RER, total treadmill-
time).
Sample collection
Subjects provided blood and nasal lavage samples at the
pre- and post-study visits. The post-study visit was con-
ducted approximately 24 hours after the last session of
exercise and at the same time of day in order to minimize
effects of circadian rhythms on sample content [4].
Blood draw
Peripheral blood (15 ml at each visit) was collected in
apyrogenic, heparinized tubes (Vacutainer, Becton Dick-
inson). Serum was separated and peripheral blood
mononuclear cells (PBMCs) were isolated by density
gradient centrifugation on Ficoll-Paque (Pharmacia).
Serum samples were quick frozen in a dry ice bath and
stored at −80°C until analysis; peripheral blood immune
cells underwent immediate analyses.
Nasal lavage
Nasal lavage was performed with a disposable metered-
dose pump filled with isotonic saline solution at room
temperature [15]. Excessive mucus was first cleared by
one spray of saline followed by a forceful exsufflation
through the nostril. The same nostril was lavaged with
6 ml of the saline solution, which remained in the nasal
cavity for approximately one minute and was then
removed. Nasal lavage fluid (NLF) was then centrifuged
to remove particulate matter and stored immediately at
−80°C.
Pro-inflammatory mediator analyses
Cytokine (ECP, IL-1β, IL-4, IL-5, IL-6, IL-13, TNFα) and
total IgE content in serum and NLF were measured via
enzyme linked immunosorbent assay (ELISA) according
to the manufacturer’s instructions (BioSource).
Cell differential analyses
Differential cell counts were performed on cells derived
from peripheral blood as described previously [4]. Cell
viability was determined via trypan blue exclusion and
cell types were differentiated using Wright-Giemsa stain
(Dade Behring Inc.). Cell differentials were determined
from at least 500 leukocytes using standard hematological
criteria.
Asthma control
Subjects completed the Juniper Asthma Control Ques-
tionnaire (ACQ) at initial and post-intervention study
visits. Asthma control was determined by the score on
the ACQ [16]. This instrument integrates common
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dilators, nocturnal symptoms, cough, activity level, and
pulmonary function. It assesses the full range of clinical
impairment that patients with asthma experience and is
highly sensitive to small changes in asthma control that
are clinically significant. Scores range from 0 to 6. Lower
scores reflect better control, and a difference of greater
than 0.5 between the pre-study score and the post-study
score is considered clinically significant. Scores greater
than or equal to 1.5 indicate poorly-controlled asthma
with a positive predictive value of 0.88 [16].
Pulmonary function analyses
Lung function was evaluated via spirometry using a
portable Multispiro spirometer (Creative Biometrics)
according to ATS/ERS guidelines [17]. Three forced vital
capacity (FVC) maneuvers were performed for each sub-
ject and predicted values (FEV1, FVC) were determined.
Statistical analysis
Baseline characteristics between sedentary and moderate
intensity groups were compared. Given the small sample
size of the pilot study, paired comparisons were made
using Fisher’s exact test for nominal characteristics (gen-
der, smoking, race) and Wilcoxon Rank Sum for con-
tinuous measures (age, FEV1, etc.). Given the
longitudinal nature of the study and the repeated out-
come measures per subject, repeated measures analysis
of variance techniques were applied to examine changes
over time and to determine if the changes in outcomes
over time differed by groups. Because repeated measures
analysis of variance assumes normally distributed out-
comes, distributional properties of the residuals from
the repeated measures analysis of variance models were
examined. Across all outcomes, only minor deviations
from the normality assumption were observed.
Results
Protocol design and subjects
Nineteen subjects were recruited into this pilot study; 16
completed the protocol (Figure 1; see Table 1 for base-
line subject characteristics). At the start of the study,Table 1 Baseline subject characteristics
Total Mode
Gender (% female) 94 88
Mean Age (range) 53 (33–78) 53 (38
Race (% non-white) 38 25
Mean BMI (range) 31.4 (17.2-48.4) 30.6 (2
Mean Asthma Control (range) 2.3 (0.7-4) 1.9 (0.7
Asthma duration≥ 10 yrs (%) 32 (1–75) 25 (1–
Smoking History (%) 19 25ninety-four percent of subjects had poor asthma control
(ACQ) as indicated by the Asthma Control Question-
naire (ACQ score ≥ 1.5) [18]. None of the baseline char-
acteristics, including gender, age, race, asthma control,
asthma duration, and smoking history, differed signifi-
cantly between the two treatment groups (Table 1).
Adherence to prescribed aerobic exercise protocols
Because of faulty heart rate monitor recordings, exercise
data from two subjects were incomplete; therefore, these
subjects were dropped from all study analyses. Com-
pleted data from heart rate monitors and exercise logs
indicated that subjects in the exercise group, on average,
performed 32 out of 36 of the prescribed exercise bouts.
Of the completed exercise bouts, 80% of these bouts
were performed for the prescribed duration and in the
prescribed target heart rate range.
Inflammatory mediators and circulating eosinophils
Figure 2 demonstrates that, at the post-study timepoint,
subjects in both the sedentary and moderate intensity
exercise groups exhibited no statistically significant dif-
ferences in either circulating mediators, including serum
ECP, or eosinophils. Subjects in the exercise group, how-
ever, exhibited a trend toward decreased eosinophilia,
which was not observed in the sedentary subjects. No
statistically significant differences were observed for the
other circulating mediators, including IL-1β, TNFα, IL-4,
IL-5, IL-6, and IL-13, as well as mediators in nasal lavage
(data not shown).
Asthma control
Figure 3 indicates that subjects in the exercise group
experienced a mean improvement in asthma control of
0.22 over the study period compared to a mean change
of 0.73 in the sedentary control group. Although these
changes were not statistically significant between groups,
such changes did exhibit a trend toward improved
asthma control within each group. The sedentary group
displayed a pronounced placebo effect with a change
greater than 0.5, which is considered clinically significant
[16,18]. It should be noted that one patient in therate intensity (n = 6) Education (n = 8) p-value
100 0.4
–62) 54 (33–78) 1
50 0.3
3.9-39.2) 32.5 (17.2-48.4) 0.5
-2.7) 2.6 (1.6-4) 0.3






















































Figure 2 Changes in circulating ECP and eosinophils between sedentary and exercise treatment groups. Serum samples were collected
from sedentary and exercise subjects at pre- and post-study timepoints. ECP levels in serum (A) were measured via ECP-specific ELISA. Cells were
harvested from the peripheral blood at pre- and post-study timepoints. Differential cell counts for (B) eosinophils were performed as described in
the text. Results are reported as percent of total peripheral blood immune cells. Black bars indicate average measurements in each group
(education: n = 8; exercise: n = 6).
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her 12 weeks of exercise, but this exacerbation did not
appear to be triggered by the exercise program. Her
study data were eventually discarded secondary to faulty
heart rate monitor recordings, thus the overall study
data were not confounded by this exacerbation.
Lung function parameters
Subjects in both treatment groups had post-
bronchodilator spirometry performed at visits before


















Figure 3 Changes in asthma control between sedentary and
exercise treatment groups. Changes in asthma control were
measured using the Asthma Control Questionnaire (ACQ). Black bars
indicate average responses in each group (education: n = 8; exercise:
n = 6).percent and the FEV1/FVC ratios of predicted for each
subject were compared between these visits. Post-
bronchodilator spirometry was chosen because home
medications were not withheld prior to visits. As shown
in Figure 4, there were no statistically significant changes
in FEV1 percent and FEV1/FVC ratios for either treat-
ment group.
Fitness levels
Parameters chosen to measure changes in fitness levels
for subjects in the exercise group pre- and post-protocol
completion included VO2 peak, HR peak, respiratory ex-
change ratio (RER), and total treadmill time during exer-
cise testing [19]. At protocol completion, subjects in the
exercise group exhibited significant increases in VO2
peak (mean change 2.64) and total treadmill time (mean
change 1.39 min) (Figure 5A, D); changes in RER (mean
change 0.04) and HR peak (mean change) displayed a
similar trend (Figure 5B, C). RER should be greater than
or equal to 1.1 with intense exercise. None of our sub-
jects, however, reached an RER of 1.1 on maximal exer-
cise, possibly due to ventilation impairment.
Discussion
The use of an exercise group and a sedentary group per-
mitted direct comparison of the effectiveness of moder-
ate intensity aerobic exercise plus education versus
education only on asthma-related responses. Interven-
tions which require a behavior change dictate the re-
cruitment of motivated individuals; however, all subjects
recruited to our study were informed that they could be
randomized to the exercise group prior to signing con-
sent. Although not all subjects were assigned to the ex-
ercise group, several potential biases (including differential





















































Figure 4 Changes in lung function between sedentary and exercise treatment groups. (A) FEV1 and (B) FEV1/FVC parameters were
measured via spirometry in sedentary and exercise subjects at pre- and post-study timepoints. Results are reported as either percent predicted



























































































Figure 5 Changes in fitness levels in exercise subjects. Subjects
randomized to the exercise treatment group performed a mandated
graded treadmill test to volitional fatigue using a modified version
of the Bruce protocol both before and upon protocol completion.
Fitness measures included A) VO2 peak, B) HR peak, C) respiratory
exchange ratio (RER), and D) total treadmill-time. Black bars indicate
average responses in each group (*p≤ 0.04 as compared with pre-
study measurements; education: n = 8; exercise: n = 6).
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includes a sedentary control group were addressed by
recruiting only subjects who were willing to engage in a
moderate intensity aerobic exercise protocol for twelve
weeks.
Results suggest that exercise training at a moderate in-
tensity improved asthma control and fitness measures in
adult asthmatics; however, the final sample did not
achieve sufficient statistical power to determine signifi-
cant differences in most outcome measures. Because all
subjects received education instruction in allergen avoid-
ance, as well as pillow and mattress protectors, it is pos-
sible that the sedentary group may have included a
greater proportion of atopic asthmatics; the atopic status
of each of the subjects was not known. If this was indeed
the case, the presence of atopy could have biased against
the effect of exercise, since avoidance would have pos-
sibly improved asthma control and, thereby, diminished
the observed effectiveness of the exercise intervention.
Although the majority of subjects self-reported having
poorly controlled asthma, neither the mean circulating ECP
levels nor eosinophil counts were elevated in these subjects.
Despite this observation, subjects in the exercise group
exhibited a trend toward decreased circulating eosinophils;
however, the serum ECP levels in these subjects were un-
changed. Such discordance between ECP levels and eosino-
phil counts may be due to exercise-mediated release of
ECP from activated eosinophils as they traffic out of the cir-
culation and into the vasculature, including the airway mu-
cosa. Previous studies, which have reported elevation of
serum ECP levels with a concomitant decrease in eosino-
phils following exercise, support this hypothesis. In these
earlier studies, serum ECP levels and circulating eosinophils
were measured during sessions of acute graded aerobic
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altitude [21] in healthy subjects. In both studies, serum
samples were collected within minutes post exercise. Both
reports demonstrated that serum ECP levels were elevated
while eosinophils counts decreased following the single, re-
spective exercise session. In contrast, additional studies
have demonstrated that physical activity has differential
effects on the circulating levels of other cytokines, in-
cluding IL-6 and TNFα [22–24]. These previous studies
differ with the present study in exercise duration, fre-
quency, subject fitness level, and/or timing of sample
collection. As such, the differences in the observed
effects of aerobic exercise on ECP and serum cytokine
measurements between the present and previous studies
are likely due to such exercise-related variables [25–30];
further, these differences underscore the need for add-
itional study.
Completion and analyses of the current pilot study
highlighted several areas that will need to be redefined
in preparation for a future, larger study. ECP, which has
been reported to correlate positively with asthma exacer-
bations and worsening [1,2], was chosen initially as a
primary outcome measure because the objective of the
future study is to test the functional consequences of
aerobic exercise on asthmatic cellular and molecular
responses. As observed in this current study, the choice
of serum ECP as the primary outcome may have lacked
sensitivity for assessing the effects of exercise on eosino-
philic inflammation; therefore, sputum ECP levels and
eosinophil counts, which better reflect the airway in-
flammation, will be used in the future study. In addition,
revised inclusion criteria will require that subjects dem-
onstrate eosinophilic inflammation at baseline in order
ensure that any impact of exercise on this outcome can
be observed. Baseline data will also include information
on measures of subjects’ atopy in order to ensure that
subjects with atopic responses are evenly distributed be-
tween the sedentary and exercise groups. Clinical out-
come measures will be expanded to include additional
lung function parameters, such as ventilatory capacity
and exercise-induced bronchospasm (EIB). Previous
results reported by Emtner and colleagues demonstrated
that adults with mild-moderate asthma who underwent
a high intensity exercise (80-90% predicted HRmax)
swimming program for 10 weeks exhibited increased
ventilatory capacity, decreased EIB, and decreased
asthma-related symptoms [31].
Conclusions
Results from this pilot study suggest that aerobic exercise
training at a moderate intensity may improve asthma con-
trol and fitness levels in the absence of asthma exacerba-
tions in adult asthmatics. Strong adherence to the exercise
protocol demonstrates the feasibility of the protocol inpreparation for a larger, clinical trial that will test the
effects of exercise on the cellular, molecular, and functional
outcome measures of the asthmatic response. Such
increased understanding will lead to the elucidation of the
potential mechanisms that underlie the beneficial effects of
moderate intensity exercise on asthmatic responses. More-
over, this understanding may lead to the development of
novel therapeutic approaches, including the use of moder-
ate intensity aerobic exercise as an adjunct therapy, for the
treatment of this chronic disease.
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